Figure 3.
Cumulative incidence functions of virologic non‐suppression, loss to follow up, transfers and mortality among pregnant females 4–24.5 months from ART start.
Cumulative incidence functions of virologic non‐suppression, loss to follow up, transfers and mortality among pregnant females 4–24.5 months from ART start.